Lancet Infect Dis • 2019.09.25
Kollef M.H., Nová?ek M., Kivistik Ü., et al.
- Clinical trial
- International
- Ceftolozane-tazobactam, Clinical trial, Drug therapy, Meropenem, Nosocomial Pneumonia
PLoS Negl Trop Dis . • 2021.02.16
Schnetterle M., Gorgé O., Nolent F., et al.
ACS Infect Dis • 2020.09.11
Davies D.T., Leiris S., Sprynski N., et al.
- New antibiotics and alternatives
- International
- beta-lactamases, Carbapenemase, Inhibitors
J Antimicrob Chemother • 2021.01.27
Theuretzbacher U., Carrara E., Conti M., et al.
Sci Rep. • 2020.01.17
Hobson C.A., Bonacorsi S., Hocquet D., et al.
Antimicrobial Agents and Chemotherapy • 2021.11.08
Wüllner D., Gesper M., Haupt A., et al.
- Bacterial mechanisms, New antibiotics and alternatives
- International
- Azithromycin, Ceftazidime, Ciprofloxacin, Colistin, Gentamicin, Levofloxacin, Lipopolysaccharide biosynthesis inhibitors, Meropenem, Piperacillin, Polymyxin B, Pseudomonas aeruginosa, Rifampicin, Tazobactam, Tigecycline, Tobramycin
Antimicrobial Chemotherapy • 2022.03.22
Poirel L., Ortiz de la Rosa J.M., Sadek M., et al.
Nature • 2022.03.24
Yang L., Shen Y., Jiang J. et al.
- Environment, Epidemiology, Surveillance
- International
- Cephalosporins, China, Colistin, Escherichia coli, Florfenicol, Livestock, Meropenem, Norfloxacin
Clinical Microbiology and Infection • 2022.06.27
Danjean M., Amaris Hobson C., Gits-Muselli M., et al.